Epigenetic changes on RASSF1A, p16, and p15 tumor suppressor genes in serum DNA have been shown to be potential biomarkers for early detection in populations at high risk for HCC [18]. The gene discussed is CDKN2A; the disease is hepatocellular carcinoma.